Anteris Technologies Global Corp. Share Price & Technical Analysis
AVR · $9.62 (+6.89%)
Healthcare / Medical Instruments & Supplies
$9.62
+6.89%
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 3 years shown)
57% return in May, -16% avg return in past 3 year May month.
82% return in 2026, 9% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 18% | 8% | -10% | 9% | 57% | – | – | – | – | – | – | – | 82% |
| 25 | 13% | 13% | -49% | 32% | -16% | -10% | -16% | 25% | 18% | 2% | -13% | 25% | 25% |
| 24 | – | – | – | – | – | – | – | – | – | – | – | -7% | -7% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Exhausted
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$626.66M
P/E ratio
—
52W high
$9.79
52W low
$2.85
Volume
22,29,468
Beta
0.59
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Anteris Technologies Global Corp. share price today?
- Anteris Technologies Global Corp. (AVR) last traded around $9.62 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AVR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AVR. Download the app for real-time alerts.
- How can I analyze Anteris Technologies Global Corp. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.